Keynote-057 Trial for High-Risk Non-Muscle Invasive Bladder Cancer - Evan Yu

November 9, 2018

(Length of Discussion: 7 min)

Evan Yu and Alicia Morgans provide a review of bladder cancer prevalence and epidemiology in current clinical trials.  This interview also includes the Keynote-057 trial results leading to plans for a phase 3 trial for a more efficacious treatment strategy for these patients with less toxicities.


Evan Yu, MD

Alicia Morgans, MD, MPH